Tags : Adoption


Roche Collaborates with Illumina to Expand the Adoption of NGS

Shots: Roche signs a 15yrs. non-exclusive agreement with Illumina, allowing patients to access next-generation sequencing (NGS) based testing in oncology Roche to get right to develop & commercialize AVENIO IVD tests for both tissue and blood to be used on Illumina’s NextSeq 550Dx System while Illumina will continue to commercialize its NextSeq 550Dx Systems and […]Read More